Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.
Cancers
Megino-Luque, Cristina C; Moiola, Cristian Pablo CP; Molins-Escuder, Clara C; López-Gil, Carlos C; Gil-Moreno, Antonio A; Matias-Guiu, Xavier X; Colas, Eva E; Eritja, Núria N
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma.
Bmc Cancer
Kim, Eun Young EY; Cho, Eun Na EN; Park, Heae Surng HS; Kim, Arum A; Hong, Ji Young JY; Lim, Seri S; Youn, Jong Pil JP; Hwang, Seung Yong SY; Chang, Yoon Soo YS
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer.
Gynecologic Oncology
Leslie, Kimberly K KK; Sill, Michael W MW; Lankes, Heather A HA; Fischer, Edgar G EG; Godwin, Andrew K AK; Gray, Heidi H; Schilder, Russell J RJ; Walker, Joan L JL; Tewari, Krishnansu K; Hanjani, Parviz P; Abulafia, Ovadia O; Rose, Peter G PG